A Method to Transit the Rotor-to-Stator Rubbing to Normal Motion Using the Phase Characteristic

A method is proposed to transit the rotor-to-stator rubbing to no-rub motion through active auxiliary bearing. The key point of this technique is to express the attractive domain of no-rub motion based on the phase characteristic and to represent the desired status. The feedback actuation is applied by an active auxiliary bearing to drive the rotor approaching the desired status. After that, the control actuation is turned off. Although the desired status is still in rubbing, it is in the attractive domain of no-rub motion, and the response of the rotor is automatically attracted to no-rub motion

Impulsive Control of the Rotor-Stator Rub Based on Phase Characteristic

An impulsive control method is proposed to eliminate the rotor-stator rubbing based on the phase characteristic. The relation between the vibration energy and the phase difference suggests the starting point for controlling the rotor-stator rubbing by implementing impulse. When the contact between the rotor and the stator occurs, the impulse is implemented in x-direction and y-direction several times to avoid the rotor-stator rubbing. The practical feasibility of this approach is investigated by numerical simulations

Screening and Identification of APOC1 as a Novel Potential Biomarker for Differentiate of Mycoplasma pneumoniae in Children

Background: Although mycoplasma pneumoniae (MP) is a common cause of community-acquired pneumonia in children, the currently used diagnostic methods are not optimal. Proteomics is increasingly being used to study the biomarkers of infectious diseases. Methods: Label-free quantitative proteomics and liquid chromatography-mass/mass spectrometry were used to analyze the fold change of protein expression in plasma of children with MP pneumonia (MPP), infectious disease control (IDC), and healthy control (HC) groups. Selected proteins that can distinguish MPP from HC and IDC were further validated by enzyme-linked immunosorbent assay (ELISA).Results: After multivariate analyses, 27 potential plasma biomarkers were identified to be expressed differently among child MPP, HC, and IDC groups. Among these proteins, SERPINA3, APOC1, ANXA6, KNTC1, and CFLAR were selected for ELISA verification. SERPINA3, APOC1, and CFLAR levels were significantly different among the three groups and the ratios were consistent with the trends of proteomics results. A comparison of MPP patients and HC showed APOC1 had the largest area under the curve (AUC) of 0.853, with 77.6% sensitivity and 81.1% specificity. When APOC1 levels were compared between MPP and IDC patients, it also showed a relatively high AUC of 0.882, with 77.6% sensitivity and 88.3% specificity. Conclusion: APOC1 is a potential biomarker for the rapid and noninvasive diagnosis of MPP in children. The present finding may offer new insights into the pathogenesis and biomarker selection of MPP in children

Route Packing: Geospatially-Accurate Visualization of Route Networks

We present route packing}, a novel (geo)visualization technique for displaying several routes simultaneously on a geographic map while preserving the geospatial layout, identity, directionality, and volume of individual routes. The technique collects variable-width route lines side by side while minimizing crossings, encodes them with categorical colors, and decorates them with glyphs to show their directions. Furthermore, nodes representing sources and sinks use glyphs to indicate whether routes stop at the node or merely pass through it. We conducted a crowd-sourced user study investigating route tracing performance with road networks visualized using our route packing technique. Our findings highlight the visual parameters under which the technique yields optimal performance

Integrated saccade latency as a measure of fatigue

INTRODUCTION: High workload, long working hours and inadequate sleep patterns can have deleterious effects on an individual’s performance. Fatigue is often linked with compromised cognitive and motor function. Our information processing system becomes overloaded and unable to monitor and suppress irrelevant information. Subsequent changes in oculomotor parameters and cortical processing times may therefore provide useful biomarkers to assess one’s state of fatigue. We propose a new non-invasive method to quantify fatigue by measuring Eye Movement And Intrinsic Latencies (EMAIL) without the use of any eye-tracking equipment. METHODS: The test is easy to perform and employs a Landolt C flanked by ring distractors. The test is presented at an eccentricity of 8°, randomly on either side of fixation point within ±5° elevation. The measurement variable is the time of presentation, δT. The subject’s task is to saccade to the peripheral target, register the orientation of the gap and respond by pressing one of four buttons. The EMAIL test measures the presentation time, δT, the subject needs to detect the peripheral target, generate an appropriate eye-movement and register the orientation of the gap. RESULTS: The EMAIL test was used to measure the stimulus presentation times needed to achieve 73% correct responses (using a one up, two down staircase). These times were subject specific and ranged from 165 to 200ms in the absence of fatigue. We investigated how, δT, is affected by exposure to other visually demanding tasks and levels of controlled fatigue. Measured integrated oculomotor responses such as latencies and visual processing times were found to increase significantly following demanding visual tasks by as much as 20ms, but only when fatigued. Preliminary findings using the EMAIL test also show that this technique can be used to investigate the effect of stimulants such as caffeine and depressants, such as alcohol. CONCLUSIONS: The EMAIL test provides a simple method to measure oculomotor parameters and to investigate how these are affected by fatigue. This method can be incorporated in the overall safety management system that is often needed in a number of work areas that involve visually-demanding and safety-critical tasks. The measured parameters provide information about an individual’s level of alertness and may also be of relevance in other industries in order to evaluate drugs developed to control fatigue

BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis

Post-translational modifications have been identified to be of great importance in cancers and lysine acetylation, which can attract the multifunctional transcription factor BRD4, has been identified as a potential therapeutic target. In this paper, we identify that BRD4 has an important role in colorectal cancer; and that its inhibition substantially wipes out tumor cells. Treatment with inhibitor MS417 potently affects cancer cells, although such effects were not always outright necrosis or apoptosis. We report that BRD4 inhibition also limits distal metastasis by regulating several key proteins in the progression of epithelial-to-mesenchymal transition (EMT). This effect of BRD4 inhibitor is demonstrated via liver metastasis in animal model as well as migration and invasion experiments in vitro. Together, our results demonstrate a new application of BRD4 inhibitor that may be of clinical use by virtue of its ability to limit metastasis while also being tumorcidal

Two nights of recovery sleep restores hippocampal connectivity but not episodic memory after total sleep deprivation

Sleep deprivation significantly impairs a range of cognitive and brain function, particularly episodic memory and the underlying hippocampal function. However, it remains controversial whether one or two nights of recovery sleep following sleep deprivation fully restores brain and cognitive function. In this study, we used functional magnetic resonance imaging (fMRI) and examined the effects of two consecutive nights (20-hour time-in-bed) of recovery sleep on resting-state hippocampal connectivity and episodic memory deficits following one night of total sleep deprivation (TSD) in 39 healthy adults in a controlled in-laboratory protocol. TSD significantly reduced memory performance in a scene recognition task, impaired hippocampal connectivity to multiple prefrontal and default mode network regions, and disrupted the relationships between memory performance and hippocampal connectivity. Following TSD, two nights of recovery sleep restored hippocampal connectivity to baseline levels, but did not fully restore memory performance nor its associations with hippocampal connectivity. These findings suggest that more than two nights of recovery sleep are needed to fully restore memory function and hippocampal-memory associations after one night of total sleep loss

Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis

Background: Vancomycin dosing is difficult in critically ill patients receiving continuous renal replacement therapy (CRRT). Previous population pharmacokinetic (PopPK) models seldom consider the effect of residual diuresis, a significant factor of elimination, and thus have poor external utility. This study aimed to build a PopPK model of vancomycin that incorporates daily urine volume to better describe the elimination of vancomycin in these patients.Methods: We performed a multicenter retrospective study that included critically ill patients who received intermittent intravenous vancomycin and CRRT. The PopPK model was developed using the NONMEM program. Goodness-of-fit plots and bootstrap analysis were employed to evaluate the final model. Monte Carlo simulation was performed to explore the optimal dosage regimen with a target area under the curve of ≥400 mg/L h and 400–600 mg/L h.Results: Overall, 113 observations available from 71 patients were included in the PopPK model. The pharmacokinetics could be well illustrated by a one-compartment model with first-order elimination, with the 24-h urine volume as a significant covariate of clearance. The final typical clearance was 1.05 L/h, and the mean volume of distribution was 69.0 L. For patients with anuria or oliguria, a maintenance dosage regimen of 750 mg q12h is recommended.Conclusion: Vancomycin pharmacokinetics in critically ill patients receiving CRRT were well described by the developed PopPK model, which incorporates 24-h urine volume as a covariate. This study will help to better understand vancomycin elimination and benefit precision dosing in these patients

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China

Background and Objectives: Studies examining the risk factors for dyskinesia in Parkinson's disease (PD) have been inconsistent, and racial differences exist. Since there have been no systematic studies of the characteristics of dyskinesia in the Mainland Chinese population, we sought to elucidate the risk factors for dyskinesia.Methods: A total of 1974 PD patients from Mainland China were systematically investigated by univariable and multivariable analyses. PD patients with and without dyskinesia were stratified into 4 groups according to levodopa equivalent daily dose (LEDD) and analyzed by a Cox proportional hazards model. A longitudinal study of 87 patients with dyskinesia was classified into 3 groups according to the duration from onset of PD to the initiation of levodopa, and comparisons among groups were analyzed by the Mann-Whitney test.Results: Early age of onset, long disease duration, being female, high LEDD, low UPDRS III scores (ON-state) and high Hoehn-Yahr stage (ON-state) were predictors of dyskinesia. Dyskinesia was levodopa dosage-dependent, and the incidence increased remarkably when LEDD exceeded 300 mg/d (p < 0.05). The emergence of dyskinesia had no association with the initiation time of levodopa, and if the latter was more than 4 years, the duration of time on chronic levodopa free of motor complications was significantly shortened.Conclusions: We found risk factors for the prediction of dyskinesia. Our data shows that physicians should be cautious if the LEDD exceeds 300 mg/d. The development of dyskinesia was not correlated with the time of levodopa initiation